Bangladesh's leading drug manufacturer Beximco Pharmaceuticals Ltd (BPL) has formally commenced marketing its products in Sri Lanka.
Beximco Pharmaceuticals Limited, a leading manufacturer of generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids in Bangladesh, today issues a trading update prior to the end of its financial year on 31 December 2005.
Bangladesh's leading anti-AIDS drug manufacturer Beximco Pharmaceuticals Limited observed the World AIDS Day today by sensitising people about the deadly AIDS.
Beximco Pharmaceuticals Ltd (BPL) has received "SAARC Country Gold Award-2005" from Sri Lanka's premier chamber, Ceylon National Chamber of Industries (CNCI). Mr. Nazmul Hassan, Chief Executive Officer of Beximco Pharmaceuticals Ltd., received the award from Mr. Macky Hasim, President of the SAARC Chamber of Commerce & Industry.
In an ambitious expansion scheme, a top Beximco company today (Thursday) unveiled plans to raise UK £ 27 million - nearly 315 crore taka - through an instrument called global depository receipt (GDR) from the United Kingdom . The stock is ready for launch next month.
The High Court today (May 2, 2005) directed Beximco Pharmaceuticals and Beximco Infusions to hold an extra-ordinary general meeting (EGM) on June 2, 2005 to get approval of their shareholders for an ambitious 'amalgamation scheme'.
Beximco Pharma Ltd. (BPL) and Dutch Bangla Bank Ltd. (DBBL) signed an agreement on 18th April, 2005 under which BPL would supply ARV (Anti Retro Viral) drugs to DBBL for 23 AIDS patient of Bangladesh.
A scientific seminar titled 'HIV Situation in Bangladesh: Role of Healthcare Providers' was held at Bangladesh-China Friendship Conference Center on 25th October, 2003.BP L organized the seminar in connection with their formal lunching of five anti-AIDS drugs for the first time in Bangladesh...